Drug Discovery World

MAY 16, 2023

What opportunities and challenges are emerging and can therapies get to market faster? Curbishley explains that as the wave of new therapies in development continues to increase, global pressures on manufacturing availability will become more acute. What are the global innovations in cell and gene therapy?

Gene Therapy 52

Gene Therapy Gene Manufacturing Marketing 52

Drug Discovery World

JANUARY 31, 2023

Mature organisations must race to deliver key new patient therapeutics while meeting market revenue expectations. The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) actively promote a quality by design (QbD) approach to ensure product quality. t is best to get an early start on these activities.

Manufacturing 98

Manufacturing Production Engineer Development 98

The Pharma Data

MAY 27, 2022

.’ This groundbreaking initiative aims to provide all of Pfizer’s patented, high-quality medicines and vaccines available in the U.S. “As we learned in the global COVID-19 vaccine rollout, supply is only the first step to helping patients. . or the European Union on a not-for-profit basis to 1.2

Vaccination 40

Vaccination Vaccine Medicine Production 40

The Pharma Data

JULY 21, 2021

Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network, which will now span three continents and include more than 20 manufacturing facilities. View the full release here: [link]. CEO and Co-founder of BioNTech.

Manufacturing 52

Manufacturing Vaccination Vaccine Clinical Trials 52

Cloudbyz

MARCH 25, 2021

market share as of 2020H1. Further, the market size of salesforce solutions is expected to reach $55,307.6mn by 2030, growing at a CAGR% of 18.9% for the period 2020-2030 (Source: PS market research). Clinical research companies have also become more thoughtful towards data security for their colossal clinical data repositories.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

Cloudbyz

MARCH 25, 2021

market share as of 2020H1. Further, the market size of salesforce solutions is expected to reach $55,307.6mn by 2030, growing at a CAGR% of 18.9% for the period 2020-2030 (Source: PS market research). Clinical research companies have also become more thoughtful towards data security for their colossal clinical data repositories.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

pharmaphorum

SEPTEMBER 29, 2020

Within the last two decades, large pharmaceutical corporations have established themselves firmly in oncology by prioritising internal R&D efforts, as well as developing and accessing novel science and technology through collaborations and alliances with biotech companies and academic institutions. A diversity of collaboration types.

Research 128

Research Gene Editing Gene Development 128

Pharmaceutical Technology

JUNE 14, 2023

With the growing number of complex therapies that require specialized packaging and handling requirements, selecting the right contract packaging organization (CPO) involves evaluating what services and additional benefits they can bring to your business.

Contract Packaging 130

Contract Packaging Packaging Packaging Development 130

The Pharma Data

JANUARY 12, 2021

supply to over 1.5 Doses are being supplied for use pursuant to the FDA Emergency Use Authorization for high-risk patients with mild to moderate COVID-19 in order to reduce the risk of progression to severe COVID-19 and/or hospitalization. government to supply our antibody cocktail as an important weapon in this fight.”

Antibody 52

Antibody Production Manufacturing Clinical Trials 52

The Pharma Data

SEPTEMBER 9, 2020

The proposed agreement is intended to provide a supply of 200 million doses and an option to purchase additional 100 million doses, with deliveries starting by the end of 2020, subject to regulatory approval. billion doses by the end of 2021. billion doses by the end of 2021. This press release features multimedia.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

DECEMBER 1, 2020

NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. As we anticipate further authorizations and approvals, we are focused on moving with the same level of urgency to safely supply a high-quality vaccine around the world. 2, 2020 07:05 UTC.

Vaccination 40

Vaccination Vaccine Manufacturing Clinical Trials 40

The Pharma Data

OCTOBER 30, 2020

Specifically, based on a potential safety signal and an unfavorable risk/benefit profile at this time, the IDMC recommends further enrollment of patients requiring high-flow oxygen or mechanical ventilation be placed on hold pending collection and analysis of further data on patients already enrolled. Cohort 1A: patients not requiring oxygen.

Production 52

Production Antibody Manufacturing Trials 52

The Pharma Data

NOVEMBER 20, 2020

“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of COVID-19 globally. Pfizer and BioNTech’s combined manufacturing network has the potential to supply up to 50 million vaccine doses globally in 2020 and up to 1.3 Filing in the U.S.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

AUGUST 18, 2020

This collaboration is expected to increase supply of REGN-COV2 to at least three and a half times the current capacity, with the potential for even further expansion. We are excited about the potential for one medicine to serve both as a treatment for those infected as well as protection for people exposed to the virus. Schleifer, M.D.,

Antibody 52

Antibody Clinical Trials Clinical Trials Manufacturing 52

The Pharma Data

DECEMBER 11, 2020

Government to supply doses in 2020 & 2021. We founded BioNTech to develop new technologies and medicines that utilize the full potential of the immune system to fight serious diseases,” said Ugur Sahin, M.D., FDA authorizes COVID-19 mRNA vaccine for emergency use; companies are prepared to deliver first doses in the U.S.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

DECEMBER 17, 2020

NASDAQ: REGN ) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19. who require oxygen therapy due to COVID-19, OR. TARRYTOWN, N.Y. ,

Antibody 52

Antibody Medicine Production Trials 52

The Pharma Data

DECEMBER 29, 2020

(NASDAQ: REGN) today announced encouraging initial data from an ongoing Phase 1/2/3 clinical trial of the Regeneron antibody cocktail, casirivimab and imdevimab, in hospitalized COVID-19 patients requiring low-flow oxygen. Infusion reactions were more common with the high dose of the antibody cocktail (2.7% Yancopoulos , M.D.,

Antibody 52

Antibody Trials Production Clinical Trials 52

The Pharma Data

OCTOBER 27, 2020

NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that the U.S. More information is available at www.passagebio.com. PHILADELPHIA, Oct. 28, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. About Krabbe Disease.

Gene Therapy 40

Gene Therapy Drugs Clinical Trials Clinical Trials 40

The Pharma Data

DECEMBER 5, 2020

Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai in New York and a trial investigator. Additionally, Regeneron bispecifics are manufactured using similar approaches used for human monoclonal antibody medicines, yielding similar properties and pharmacokinetics. About Regeneron Pharmaceuticals, Inc.

Antibody 40

Antibody Production Trials Medicine 40

The Pharma Data

NOVEMBER 5, 2020

FDA accepted for priority review Libtayo ® (cemiplimab-rwlc) for both advanced non-small cell lung cancer and basal cell carcinoma. In 2021, we look forward to important potential launches including for our PD-1 inhibitor Libtayo in non-small cell lung cancer and advanced basal cell carcinoma. and non-GAAP diluted EPS (1) was $8.36 .

Sales 52

Sales Production Manufacturing Antibody 52

Drug Discovery World

NOVEMBER 27, 2023

The ability to respond to changes in patient and customer needs is a constant challenge in the pharmaceutical industry, with ever-evolving requirements influencing even the earliest stages of the drug discovery pipeline. As a result, different tests with more complex data structures will be required.

Drugs 52

Drugs Marketing Scientist Medicine 52

pharmaphorum

MARCH 30, 2021

For example, helping patients with rare diseases requires us to build strong partnerships with experienced stakeholders, because only by working together can we improve the path to access for innovative therapies, which in turn improves the lives of the patients we are committed to.”. Rare diseases during COVID.

Genetics 111

Genetics Marketing Development Genome 111

The Pharma Data

NOVEMBER 20, 2020

Casirivimab and imdevimab are not authorized for use in patients who are hospitalized or require oxygen therapy due to COVID-19, or for people currently using chronic oxygen therapy because of an underlying comorbidity who require an increase in baseline oxygen flow rate due to COVID-19. . Schleifer, M.D.,

Antibody 52

Antibody Production Clinical Trials Clinical Trials 52

XTalks

AUGUST 2, 2023

With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions. In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

DECEMBER 21, 2020

Galidesivir treatment was associated with a more rapid decline in viral RNA levels in the respiratory tract in an apparent dose-dependent manner. It is in advanced development for the treatment of Marburg virus disease. Post-marketing commitments for RAPIVAB are ongoing. government agencies and other institutions.

RNA 52

RNA Clinical Trials Clinical Trials Trials 52

The Pharma Data

NOVEMBER 21, 2020

Casirivimab and imdevimab are not authorized for use in patients who are hospitalized or require oxygen therapy due to COVID-19, or for people currently using chronic oxygen therapy because of an underlying comorbidity who require an increase in baseline oxygen flow rate due to COVID-19. . Schleifer , M.D.,

Antibody 40

Antibody Production Clinical Trials Clinical Trials 40

FDA Law Blog

JANUARY 24, 2024

Karst — In September 2022, while the world was still in the midst of the COVID-19 epidemic and dealing with significant supply chain woes, President Biden issued an Executive Order— Executive Order 14081 —titled “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy.”

Manufacturing 69

Manufacturing Drugs Generic Pharmaceutical Production 69

The Pharma Data

OCTOBER 29, 2020

Established ULTOMIRIS as new standard of care in PNH ahead of set goal, with more than 70% patient conversion from SOLIRIS ® (eculizumab) in 3 largest markets – U.S. Treatment compliance rates across all our medicines have remained strong and continue to be slightly above expectations. Received U.S. Germany & Japan.

Sales 40

Sales Clinical Trials Clinical Trials Production 40

pharmaphorum

JANUARY 4, 2023

Because these products can be efficiently manufactured in large batches, the approach eases some of the challenges associated with autologous cell therapies (in which a patient’ cells are collected, genetically modified, and then returned to the patient) and offers the potential to accelerate time to therapy and broaden access globally.

Gene Therapy 97

Gene Therapy Manufacturing Gene Production 97

The Pharma Data

JUNE 24, 2021

Effort is part of the companies’ recent pledge of two billion doses to ensure global equitable access to the vaccine. COVID-19 has impacted everyone, everywhere, and to win the battle against this pandemic, we must ensure expedited access to vaccines for all. NEW YORK & MAINZ, Germany–(BUSINESS WIRE)– Pfizer Inc.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52

The Pharma Data

MAY 4, 2021

Enters Into Contracts to Supply BNT162b2 to Canada and Israel for Periods Beyond 2021; Currently Negotiating Similar Potential Contracts with Multiple Other Countries. Frank D’Amelio, Chief Financial Officer and Executive Vice President, Global Supply, stated: “I am very happy with the performance of all of our therapeutic areas this quarter.

Vaccination 40

Vaccination Vaccine Production Sales 40

Pharmaceutical Technology

JUNE 8, 2023

Firms in the pharmaceutical industry – as with those in many advanced sectors – have become increasingly preoccupied with environmental, social and governance (ESG) goals in recent years. AstraZeneca has announced its supply chain will be carbon negative by 2030. Supply chains are increasingly in the spotlight.

Production 130

Production Manufacturing Marketing Medicine 130

Pharmaceutical Technology

NOVEMBER 28, 2022

Technology has now advanced to the extent that wearing a device can remotely monitor multiple vital signs such as heart rate, temperature, respiratory condition and blood pressure. The Edinburgh-based business is attracting global attention for its advanced medical-grade devices for monitoring vital signs. There is no more room.

Life Science 130

Life Science Engineer Packaging Packaging 130

The Pharma Data

MAY 14, 2021

Click here to get Legendary Potency at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. the famous “Battle of 300,” Chinese Emperors, Egyptian Pharaohs, polygamous Mormons, middle eastern Sultans, and more.

Production 52

Production Containment Scientist Drugs 52

Pharmaceutical Technology

FEBRUARY 15, 2023

The supply chain revolution is already underway, accelerated by the Covid-19 pandemic. Internet of Things (IoT) devices can monitor shipments from vial to patient, while artificial intelligence (AI) and machine learning are making once laborious processes faster and more efficient than ever before, saving time and labour costs.

Big Data 130

Big Data Manufacturing Production Vaccination 130

XTalks

SEPTEMBER 14, 2020

Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19. In early August, the federal government in Ottawa also secured an agreement with Moderna to provide up to 56 million doses of its vaccine upon approval.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92